- Reaction score
- 338
My understanding of the situation is that follica did studies for alternative topicals than minoxodil to use in tandem with their wounding device but with poor results. The one I remember was with lithium gluconate.
Basically they investigated other topicals and those other topicals + skin disruption were inferior to minoxodil + skin disruption.
http://www.hairlosscure2020.com/fol...ts-a-best-case-scenario-release-date-of-2018/
Conjecture:
Follica really wants a topical they can patent to go with their wounding device and that is what they have spent all this time trying to get. They failed to get anything better than minoxodil or some cocktail containing monoxodil.
Basically they investigated other topicals and those other topicals + skin disruption were inferior to minoxodil + skin disruption.
http://www.hairlosscure2020.com/fol...ts-a-best-case-scenario-release-date-of-2018/
Conjecture:
Follica really wants a topical they can patent to go with their wounding device and that is what they have spent all this time trying to get. They failed to get anything better than minoxodil or some cocktail containing monoxodil.